Higher Physical Activity Levels Can Increase Life Expectancy
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, Nov. 15, 2024 -- Higher physical activity (PA) levels can increase life expectancy, according to a study published online Nov. 14 in the British Journal of Sports Medicine.
Lennert Veerman, M.D., M.P.H., Ph.D., from the Griffith University School of Medicine and Dentistry in Gold Coast, Australia, and colleagues estimated how much low PA reduces life expectancy by applying a predictive model based on device-measured PA risk estimates and a life-table model analysis among adults aged 40 years and older. In addition, the authors examined how much life expectancy could be improved by increasing PA levels.
The researchers found that Americans older than 40 years could live an extra 5.3 years if all individuals were as active as the top 25 percent of the population. Individuals in the lowest activity quartile had the greatest gain in lifetime per hour of walking, where an additional hour of walking could add 376.3 minutes of life expectancy.
"Higher PA levels provide a substantial increase in population life expectancy. Increased investment in PA promotion and creating PA promoting living environments can promote healthy longevity," the authors write. "Infrastructure measures that encourage active transport, walkable neighborhoods as well and green spaces might be promising approaches to increase PA and resultant healthy life expectancy at the population level."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-17 00:00
Read more
- What You Need to Know About FluMist, the Nasal Flu Vaccine
- Malaria Developing Resistance to Drug That Saves Children's Lives
- Exercise Cuts Dependence in Those With Alcohol Use Disorder
- Early TAVR Beneficial for Asymptomatic Severe Aortic Stenosis
- 1 in 4 Moms Fall Asleep While Breastfeeding, Putting Babies at Risk for SIDS
- Arrowhead Pharmaceuticals Presents New Data at AHA24 from PALISADE Phase 3 Study and Open-Label Extension from MUIR and SHASTA-2 Studies of Plozasiran
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions